Long Term Growth

MK Biological Sciences, LP invests in public biotechnology companies that are engaged in bringing novel therapeutics and/or diagnostics to market. Emphasized spaces include cancer/oncology, modulation of the inflammatory response, infectious diseases and neurosciences. Of considerable interest are companies that are investigating novel, first-in-class platforms that may be applicable to multiple disease types.